CM
DGX icon

Caption Management’s Quest Diagnostics DGX Stock Holding History

Caption Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,900
Closed -$880K – 1744
2025
Q2 		$880K Buy
+4,900
New +$851K 0.01% 971
2024
Q1 		– Sell
-3,000
Closed -$414K – 1303
2023
Q4 		$414K Sell
3,000
-4,500
-60% -$592K 0.01% 1006
2023
Q3 		$914K Buy
+7,500
New +$999K 0.01% 788

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Caption Management's DGX Position: Q3 2025 in Review

Caption Management sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 4,900 shares — an estimated $880K sold.

Caption Management first reported a position in DGX in Q3 2023 and held it in 3 quarters. The position peaked at $914K in Q3 2023. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Caption Management reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Caption Management sold 4,900 Quest Diagnostics shares in Q3 2025, an estimated $880K.
  • Caption Management first reported a position in Quest Diagnostics in Q3 2023 and held it in 3 quarters.
  • Caption Management's Quest Diagnostics position peaked at $914K in Q3 2023.
  • 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.